MAPping tubulin mutations
Thomas D Cushion1,2, Ines Leca2, David A Keays1,2,3
1Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Abstract:
Microtubules are filamentous structures that play a critical role in a diverse array of cellular functions including, mitosis, nuclear translocation, trafficking of organelles and cell shape. They are composed of α/β-tubulin heterodimers which are encoded by a large multigene family that has been implicated in an umbrella of disease states collectively known as the tubulinopathies. De novo mutations in different tubulin genes are known to cause lissencephaly, microcephaly, polymicrogyria, motor neuron disease, and female infertility. The diverse clinical features associated with these maladies have been attributed to the expression pattern of individual tubulin genes, as well as their distinct Functional repertoire. Recent studies, however, have highlighted the impact of tubulin mutations on microtubule-associated proteins (MAPs). MAPs can be classified according to their effect on microtubules and include polymer stabilizers (e.g., tau, MAP2, doublecortin), destabilizers (e.g., spastin, katanin), plus-end binding proteins (e.g., EB1-3, XMAP215, CLASPs) and motor proteins (e.g., dyneins, kinesins). In this review we analyse mutation-specific disease mechanisms that influence MAP binding and their phenotypic consequences, and discuss methods by which we can exploit genetic variation to identify novel MAPs.
Insights
Microtubule (MT) gene mutations cause tubulinopathies, impacting cellular functions and leading to diverse diseases. This review explores how MT mutations affect microtubule-associated proteins (MAPs) and disease mechanisms.
Area of Science:
- Cell Biology
- Genetics
- Neuroscience
Background:
- Microtubules, composed of α/β-tubulin heterodimers, are crucial for cell division, organelle transport, and cell shape.
- Mutations in tubulin genes cause tubulinopathies, a group of diseases including lissencephaly, microcephaly, and motor neuron disease.
- The diverse clinical presentations of tubulinopathies are linked to specific tubulin gene expression and function.
Purpose of the Study:
- To review mutation-specific disease mechanisms in tubulinopathies.
- To analyze how tubulin mutations impact microtubule-associated proteins (MAPs) and their binding.
- To discuss strategies for identifying novel MAPs using genetic variation.
Main Methods:
- Literature review of studies on tubulin mutations and their effects on microtubules.
- Analysis of the classification and function of microtubule-associated proteins (MAPs).
- Exploration of genotype-phenotype correlations in tubulinopathies.
Main Results:
- Tubulin mutations significantly alter MAP binding, influencing microtubule dynamics and cellular functions.
- Different tubulin mutations lead to distinct phenotypic consequences due to specific MAP interactions.
- Understanding these interactions provides insights into disease pathogenesis.
Conclusions:
- Tubulinopathies arise from complex interactions between mutated tubulin and MAPs.
- Targeting these interactions may offer therapeutic strategies for neurological and developmental disorders.
- Genetic variation analysis is a promising approach for novel MAP discovery.
More Related Videos
07:21Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
Published on: November 17, 2023
06:30Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications
Published on: October 11, 2024
Related Concept Videos
Microtubule Instability
Destabilization of Microtubules
Drugs that Stabilize Microtubules
Microtubule Associated Proteins (MAPs)
Drugs that Destabilize Microtubules
Microtubule Formation
